Sujata Tyagi Dayal
Director · Emergent BioSolutions Inc.
- 2025
- May 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sujata Tyagi Dayal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald W. Degolyer - $444K in EBS purchases and sales in the last 12 months
- Kathryn C. Zoon - $144K in EBS purchases and sales in the last 12 months
- Keith Katkin - $128K in EBS purchases and sales in the last 12 months
- Paul Anthony Williams - $79K in EBS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sujata Tyagi Dayal?
Sujata Tyagi Dayal is a corporate insider, tracked as Director of Emergent BioSolutions Inc. (EBS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sujata Tyagi Dayal last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 2 filings going back to 2025.
Has Sujata Tyagi Dayal been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($201K) across all tracked filings.
